Old Web
English
Sign In
Acemap
>
Paper
>
Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy
Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy
2017
M. Guglieri
Paula R. Clemens
Avital Cnaan
J. Damsker
A. Arrieta
Lauren P. Morgenroth
R. Davis
C Olsen
R. Head
Kanneboyina Nagaraju
Yetrib Hathout
J Haberlová
D. Athanasiou
Elizabeth Vroom
K. Bushby
Eric P. Hoffman
Keywords:
Physical therapy
Duchenne muscular dystrophy
Drug development
Medicine
Pediatrics
Diabetes mellitus
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]